Activation of oncogenic KRAS and PIK3CA pathways and inactivation of tumor suppressor genes, ARID1A and PTEN, are observed in clear cell and endometrioid ovarian carcinomas, respectively [26]. The gene discussed is PTEN; the disease is ovarian endometrioid carcinoma.